ADIPOQ and Insulin resistance: Visceral adiposity associated with metabolic syndrome and further complications leads to the initiation of chronic inflammation (connected with a shift toward proinflammatory macrophages yielding the secretion of IL-6 and TNF-α), disturbances in the adipokines profile (augmented leptin secretion paralleled by decreased adiponectin), and insulin resistance development [83].